Address
Lux Capital Management
295 Madison Avenue
24th Floor
New York, NY 10017
United States
Phone
Website
Industry
Recent investment activity
KANDO id: 3552
Corporate information
Registration country
Company type
Research-driven investment firm focused on founding, seed and early stage investments in the physical and life sciencesFunds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Lux Ventures V LP | Venture | 2017 | USD | 400,000,000 |
| Lux Ventures IV LP | Venture | 2015 | USD | 350,000,000 |
| Lux Ventures Cayman III LP | Venture | 2012 | ||
| Lux Ventures III Special Founders Fund LP | Venture | 2012 | ||
| Lux Ventures III LP | Venture | 2011 | USD | 245,000,000 |
| Lux Ventures III LP | Venture | 2011 |
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 20 of 60| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_company.png?itok=-3VkoHwg){kind=icon}
|
Atair Aerospace Inc | N/A | ||||
|
|
Cerulean Pharma Inc | Series A | ||||
|
|
Cerulean Pharma Inc | Series B | ||||
|
|
Cerulean Pharma Inc | Series C | ||||
|
|
Cerulean Pharma Inc | Series D | ||||
|
|
Everspin Technologies Inc | N/A | ||||
|
|
Genocea Biosciences Inc | Series B | ||||
|
Gridco Systems Inc | Provider of grid infrastructure solutions for electric power distribution system operators. | N/A | |||
|
|
Kereos Inc | Kereos, Inc. develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease. | N/A | |||
|
|
Kurion | Kurion combines robots and breakthrough chemical engineering to eliminate nuclear waste. | N/A | |||
|
|
Kymeta | Kymeta uses the physics of metamaterials to make satellite antennas as thin as paper. | N/A | |||
|
Luxtera Inc | N/A | ||||
|
|
Magen BioSciences Inc | N/A | ||||
|
|
Silicon Clocks Inc | N/A | ||||
|
|
Transphorm Inc | A redefined power conversion company. | Series C | |||
|
|
Visterra Inc | A biotechnology company discovering and developing innovative products that will transform the prevention and treatment of infectious diseases. | Series A | |||
|
|
3scan Inc | Developer of ultra-high resolution, 3D brain scans and digital organ reconstruction. | N/A | |||
|
|
Accelergy Corp | N/A | ||||
|
Alluvium Inc | Developer of software that applies machine learning to mechanical data. | Seed led the round | |||
|
|
Angstrom Publishing | N/A |
Current employees
| Employee | Position | ||
|---|---|---|---|
![[node:title] photo](/sites/default/files/styles/icon/public/default_images/_person_0.png?itok=nkWWtsDD){kind=icon}
|
Peter Hébert (founder) | ||
|
|
Robert Paull (founder) | ||
|
|
Josh Wolfe (founder) | ||
|
|
Tuvia Barak | ||
|
|
Shahin Farshchi | ||
|
Adam Goulburn | ||
|
|
Zack Schildhorn | ||
|
|
Bilal Zuberi | ||
|
|
Richard Foster | ||
|
|
R. James Woolsey |